Retraction of Diabetologia
DOI 10.1007/s00125-010-1831-8
This article has been retracted by the Editor-in-Chief of Diabetologia following the discovery of redundant publication (part of Figure 2c was previously published in Cardiovascular Research; doi:10.1093/cvr/cvn226).
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00125-010-1831-8.
About this article
Cite this article
Hattori, Y., Jojima, T., Tomizawa, A. et al. Retraction Note: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells. Diabetologia 55, 533 (2012). https://doi.org/10.1007/s00125-011-2394-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-011-2394-z